Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan · Delayed Price · Currency is JPY 3,550.00
+30.00 (0.85%)
Sep 14, 2026, 3:30 PM JST
Towa Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 173,282 | 197,158 | 131,879 | 142,933 | 93,275 | 135,736 | |
Market Cap Growth | 17.92% | 49.50% | -7.73% | 53.24% | -31.28% | 12.90% |
Enterprise Value | 360,980 | 390,997 | 326,106 | 308,406 | 222,967 | 195,152 |
Last Close Price | 3520.00 | 4005.00 | 2618.17 | 2770.63 | 1771.34 | 2492.57 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.96 | 37.55 | 6.95 | 8.84 | 42.38 | 8.53 |
Forward PE | 7.50 | 9.78 | 8.37 | 11.99 | 11.96 | 8.06 |
PS Ratio | 0.62 | 0.72 | 0.51 | 0.63 | 0.45 | 0.82 |
PB Ratio | 0.95 | 1.11 | 0.77 | 0.92 | 0.68 | 1.03 |
P/TBV Ratio | 1.11 | 1.30 | 1.05 | 1.36 | 1.11 | 1.74 |
P/FCF Ratio | 40.45 | 24.19 | - | - | - | 12.35 |
P/OCF Ratio | 6.86 | 6.48 | 5.64 | 17.41 | 36.67 | 6.13 |
PEG Ratio | 0.11 | 5.58 | 5.58 | 5.58 | 5.58 | 7.28 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.29 | 1.43 | 1.26 | 1.35 | 1.07 | 1.18 |
EV/EBITDA Ratio | 7.67 | 8.51 | 7.52 | 8.68 | 8.95 | 6.62 |
EV/EBIT Ratio | 14.78 | 16.92 | 14.03 | 17.48 | 40.43 | 10.53 |
EV/FCF Ratio | 84.26 | 47.96 | - | - | - | 17.76 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.26 | 1.29 | 1.38 | 1.32 | 1.26 | 1.09 |
Debt / EBITDA Ratio | 4.89 | 4.98 | 5.45 | 5.80 | 6.94 | 4.89 |
Debt / FCF Ratio | 53.67 | 28.09 | - | - | - | 13.12 |
Net Debt / Equity Ratio | 1.03 | 1.03 | 1.11 | 1.13 | 1.09 | 0.84 |
Net Debt / EBITDA Ratio | 3.99 | 4.00 | 4.40 | 4.97 | 5.97 | 3.77 |
Net Debt / FCF Ratio | 43.81 | 22.53 | -35.78 | -5.96 | -5.68 | 10.13 |
Asset Turnover | 0.59 | 0.58 | 0.58 | 0.57 | 0.60 | 0.57 |
Inventory Turnover | 1.48 | 1.51 | 1.58 | 1.51 | 1.64 | 1.43 |
Quick Ratio | 1.20 | 1.23 | 1.33 | 1.26 | 1.00 | 0.73 |
Current Ratio | 2.82 | 2.76 | 2.81 | 2.72 | 2.33 | 1.45 |
Return on Equity (ROE) | - | 3.00% | 11.59% | 11.05% | 1.64% | 12.79% |
Return on Assets (ROA) | - | 3.05% | 3.22% | 2.75% | 0.98% | 4.03% |
Return on Invested Capital (ROIC) | 3.22% | 2.54% | 4.82% | 3.78% | 1.00% | 6.29% |
Return on Capital Employed (ROCE) | 6.40% | 6.10% | 6.10% | 5.00% | 1.90% | 8.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.77% | 2.66% | 14.40% | 11.31% | 2.36% | 11.72% |
FCF Yield | 2.47% | 4.13% | -4.04% | -20.74% | -28.07% | 8.10% |
Dividend Yield | 2.33% | 2.00% | 2.67% | 2.17% | 3.39% | 2.29% |
Payout Ratio | 47.73% | 74.99% | 15.55% | 18.25% | 140.84% | 15.15% |
Buyback Yield / Dilution | -0.00% | -0.01% | -0.01% | 0.00% | 2.19% | 1.86% |
Total Shareholder Return | 2.33% | 1.99% | 2.67% | 2.17% | 5.58% | 4.15% |